Cirrhosis is not a predictor of response with interferon and ribavirin retreatment of hepatitis C.

被引：0
|
作者：
Waters, B [1 ]
Ismail, MK [1 ]
Fleckenstein, JF [1 ]
Zua, MS [1 ]
Smith, JL [1 ]
Bockhold, KM [1 ]
Riely, CA [1 ]
机构：
[1] Univ Tennessee, Memphis, TN USA
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
L0476
引用
收藏
页码：A1287 / A1287
页数：1
相关论文
共 50 条
  • [41] Retreatment of Egyptian Chronic Hepatitis C Patients Not Responding to Pegylated Interferon and Ribavirin Dual Therapy
    Aboushady, Mohamed
    Alwassief, Ahmed
    Abdelrazik, Mohamed
    Ziada, Dina
    Shahba, Hossam
    Elmestikawy, Amr
    Elbahrawy, Ashraf
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (09): : 539 - 546
  • [42] Cognitive function does not worsen during pegylated interferon and ribavirin Retreatment of chronic hepatitis C
    Fontana, Robert.
    Biebauskas, Linas A.
    Lindsay, Karen L.
    Back-Madruga, Carla
    Wright, Elizabeth C.
    Snow, Kristin K.
    Lok, Anna S. F.
    Kronfol, Ziad
    Padmanabhan, Latha
    HEPATOLOGY, 2007, 45 (05) : 1154 - 1163
  • [43] Outcomes of treatment of hepatitis C cirrhosis with pegylated interferon-alpha and ribavirin
    Kong, J.
    Kontorinis, N.
    Studd, C.
    Tarquinio, L.
    Nazareth, S.
    McInerney, M.
    Cheng, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A293 - A294
  • [44] Efficacy and tolerability of pegylated interferon and ribavirin in patients with hepatitis C related cirrhosis
    Macesic, N.
    Ratnam, D.
    Pianko, S.
    Dev, A.
    Sievert, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A281 - A282
  • [45] Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis
    Koshy, A
    Marcellin, P
    Martinot, M
    Madda, JP
    LIVER, 2000, 20 (04): : 335 - 339
  • [46] Genotypes 1 and 3 as predictors of response to alpha interferon ribavirin combination in Brazilians with chronic hepatitis C.
    Bassit, L
    RibeirodosSantos, G
    SaezAlquezar, A
    Chamone, DF
    Barros, MFA
    Marujo, WC
    Curry, RA
    SetteJunior, H
    HEPATOLOGY, 1997, 26 (04) : 353 - 353
  • [47] Improved antiviral sustained response when combining consensus interferon and ribavirin for the treatment of chronic hepatitis C.
    Sjogren, MH
    Holtzmuller, K
    Sjogren, RW
    HEPATOLOGY, 2001, 34 (04) : 338A - 338A
  • [48] A simple model can predict response to interferon-ribavirin in genotype 1 chronic hepatitis C.
    Martinez-Bauer, E
    Forns, X
    Barrera, JM
    Costa, J
    Sanchez-Tapias, JM
    HEPATOLOGY, 2003, 38 (04) : 640A - 641A
  • [49] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Goncales, Fernando L., Jr.
    Moma, Camila A.
    Vigani, Aline G.
    Angerami, Adriana F. C. F.
    Goncales, Eduardo S. L.
    Tozzo, Raquel
    Pavan, Maria H. P.
    Goncales, Neiva S. L.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [50] Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
    Fernando L Gonçales
    Camila A Moma
    Aline G Vigani
    Adriana FCF Angerami
    Eduardo SL Gonçales
    Raquel Tozzo
    Maria HP Pavan
    Neiva SL Gonçales
    BMC Infectious Diseases, 10
12345